Screening and identification of a novel PGAM5-specific inhibitor for attenuating multi-organ injury
These findings establish PGAM5 as a druggable target in organ injury and identify PD as a natural compound with favorable safety and strong translational potential, providing a foundation for necroptosis-targeted therapeutic development.
Authors
- Guotao Lu
- Weiming Xiao
- Keyan Wu
- Bo Tu
- Xiaowu Dong
- Xiaoyu Zhu
- Weiwei Chen
- Xinyi Liu
- Weijuan Gong
- Wei Li
- Dan Ji
- Haibo Li
- Zifan Ding
- Lin Chen
- Qingtain Zhu
- Chenchen Yuan
- Xingmeng Xu
Institutions
- Toho University (JP)
- Central South University (CN)
- Fred Hutch Cancer Center (US)
- He Eye Hospital (CN)
- Xiangya Hospital Central South University (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- Journal of Advanced Research
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jare.2026.01.075
- Primary Topic
- Cell death mechanisms and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00